US 8742129
Crystalline forms of febuxostat
granted A61PA61P19/06
Quick answer
US patent 8742129 (Crystalline forms of febuxostat) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P19/06